Organisations representing the wheat industry in the US, Canada and Australia announced on Thursday that they will work toward the goal of synchronised commercialisation of biotech traits in the wheat crop.
Noting that "none of us holds a veto over the actions of others," they agreed that it was in the best interest of all three producer communities to introduce biotechnology in a coordinated fashion to minimise market disruption.
The announcement came in a statement of joint principles on the issue of biotechnology in wheat, which has been a sensitive subject in some parts of the world, including major export markets like the European Union and Japan.
There is currently no commercial production of genetically modified (GM) wheat anywhere in the world.
The statement highlighted the importance of wheat to the food supply and the impact of the declining acres in all three countries due, in part, to competition from crops that have the advantage of biotech traits.
The statement also noted the slow growth trend of wheat yields compared to those for other crops and the lack of public and private investment in wheat research worldwide.
Noting that biotechnology is not the only answer to a host of agronomic questions facing wheat production, the groups agreed that it could be a "significant component" to tackling major issues facing wheat production.
Australian signatories include the Grains Council of Australia, Grain Growers Association and Pastoralists & Graziers Association of Western Australia (Inc.).
US organisations signing onto the statement include the National Association of Wheat Growers, US Wheat Associates and the North American Millers' Assn. Canadian signatories include Grain Growers of Canada, the Western Canadian Wheat Growers Assn. and the Alberta Winter Wheat Producers Commission.